months) The reasons for switching the GLP-1RA therapies were categorized into treatment-related discontinuations (i.e., injection burden, non-response), symptom-related (i.e., nausea, vomiting, dyspepsia, diarrhea, constipation, malnutrition), and access/coverage-related (shortage, insurance denial)
Beyond weight loss: How GLP-1 drugs are reshaping wellness norms webinar This webinar, hosted by Nutrition Business Journal's Bill Giebler and Suzy's Melissa Dunn, will explore how GLP-1 medications like Ozempic and Wegovy are reshaping health, wellness and weight management
Month 6: Full protocol benefits realized
Please be sure to let your provider, whether visiting one of our facilities or elsewhere, know if you are taking a GLP-1 weight loss medication, as it may impact other conditions